1. HIV entry inhibition by the envelope 2 glycoprotein of GB virus C.
- Author
-
Jung S, Eichenmüller M, Donhauser N, Neipel F, Engel AM, Hess G, Fleckenstein B, and Reil H
- Subjects
- Cells, Cultured, Dose-Response Relationship, Drug, GB virus C physiology, Humans, Recombinant Fusion Proteins pharmacology, Transfection, Viral Envelope Proteins genetics, Viral Envelope Proteins pharmacology, Virus Replication drug effects, HIV Infections virology, HIV-1 physiology, Viral Envelope Proteins physiology, Virus Replication physiology
- Abstract
Epidemiological studies have revealed an association between GB virus C (GBV-C) long-term viraemia and ameliorated HIV disease progression. We have provided evidence that a single protein of GBV-C, the glycoprotein E2, interferes with early HIV replication steps of both X4- and R5-tropic HIV strains. Preincubation with anti-E2 antibody specifically abrogates the inhibitory effect. Results were confirmed by the in-vitro expression of GBV-C E1/E2 encoding RNA.
- Published
- 2007
- Full Text
- View/download PDF